Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Step up against cancer: study links daily walks to better treatment outcomes

NCT ID NCT06668402

Knowledge-focused Sponsor: Gazi University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 18, 2026 · Updated 1 time

Summary

This study looked at whether being more physically active, measured by daily steps, helps rectal cancer patients respond better to chemotherapy and radiation before surgery. About 120 participants wore smartwatches to track their steps, heart rate, and sleep. The goal was to see if higher step counts led to a higher chance of having no cancer left at the time of surgery. The results could help create exercise guidelines for cancer patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

160 people

The number who actually took part.

Started

Oct 2024

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study will involve adult patients diagnosed with locally advanced rectal cancer (stages II and III) who are scheduled to receive total neoadjuvant therapy (TNT), which includes chemotherapy and radiotherapy prior to surgery. Participants are required to have sufficient physical capacity for regular activity monitoring via a wearable smartwatch, which will collect data on physical activity, heart rate, and sleep quality. Stage I and metastatic (stage IV) rectal cancer patients are excluded, as they are not candidates for TNT. The study population represents individuals who are eligible for this preoperative treatment and can benefit from objective monitoring of activity as part of their treatment response assessment.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 years and older. * Diagnosed with locally advanced rectal cancer (stage II or III) and eligible for total neoadjuvant therapy (TNT). * Planned to undergo chemotherapy and radiotherapy as part of neoadjuvant treatment before surgery. * Capable of providing informed consent. * Able to wear and operate the Huawei Watch Fit 2 smartwatch throughout the treatment period. * Sufficient mobility to engage in physical activity, including walking, as per study requirements. * Willing to complete weekly monitoring visits and complete the EORTC QLQ-C30 and Pittsburgh Sleep Quality Index questionnaires at baseline and study end Exclusion Criteria: * Stage I or metastatic (stage IV) rectal cancer. * Contraindications to physical activity, including but not limited to severe cardiovascular or respiratory conditions that limit mobility. * Prior treatment for rectal cancer with chemotherapy or radiotherapy. * Use of a pacemaker or other implanted medical devices that might interfere with smartwatch functionality. * Known allergic reaction to materials in the Huawei Watch Fit 2 smartwatch. * Severe cognitive or psychological disorders that would hinder participation in the study or completion of questionnaires. * Any medical or psychiatric condition that, in the opinion of the investigator, may compromise patient safety or interfere with study adherence.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Exercise are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Motor Activity rectal cancer rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Exercise Quality of life (QOL) Rectal tumors Smart watch Total neoadjuvant treatment

Contacts and locations

Locations

  • Etlik City Hospital

    Ankara, Yenimahalle, 06170, Turkey (Türkiye)

  • Gazi University

    Ankara, Yenimahalle, 06560, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.